Pharmaceutical education is undergoing a dynamic transformation, driven by the evolving healthcare landscape, technological advancements, and the need for highly skilled professionals. To support pharmaceutical education reform in WPR, FIP through the UNITWIN Network on Global Pharmacy Education Development, in collaboration with UNESCO and University College London (UCL), is establishing the FIP-UNESCO UNITWIN Centre for Excellence in Western pacific region.

Moderator
- Dalia Bajis , FIP Senior programme lead , FIP , The Netherlands
Co-Moderator
- Genuine Desireh , FIP Educational partnerships and projects manager ,FIP , The Netherlands
Panellists
- Catherine Duggan ,FIP CEO , FIP , The Netherlands
- Ralph J. Altiere , FIPEd Chair , FIP and University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences, USA
- Paul Gallagher, Deputy Head-Clinical, Department of Pharmacy and Pharmaceutical Sciences, Faculty of Science, National University of Singapore, Singapore
- John Jackson, President , Western Pacific Pharmaceutical Forum , Australia
- Nisa Masyitah, FIP Project and Data Support Coordinator, FIP
Netherlands
- Lilian M. Azzopardi , Head, Department of Pharmacy , University of Malta , Malta

Pregnant women and mothers often encounter bias by being viewed as inconveniences or liabilities by their employers. Their ability to perform quality work is also presumed to be compromised due to their pregnancy or motherhood responsibilities. Insufficient support and workplace policies exacerbate these challenges, including the absence of flexible work arrangements and adequate accommodations like maternity leave.
These inequities impact women across various sectors; however, they are particularly evident within the health and pharmacy workforce since women represent over 70% of the workforce in the health and social sectors1. To address these issues and inequities, it is crucial to challenge and dismantle the gender biases and stereotypes that perpetuate discrimination against pregnant women and mothers. EquityRx and FIPWiSE (Women in Science and Education) are hosting a digital event to highlight and address some of these issues, particularly those related to maternity leave policies.

There are 1.25 billion adult tobacco users around the world, and 60% of them want to quit, but only around 35% of the world’s population have access to comprehensive tobacco cessation services. Given the global prevalence and burden of tobacco use, particularly as a risk factor for noncommunicable diseases, it is important that the services provided by pharmacists in this area are expanded and consolidated. At this event, FIP will launch a global intelligence report on pharmacist-led tobacco cessation services. A joint WHO-FIP statement and call to action on the role of pharmacists in tobacco cessation and examples of successful pharmacist interventions/services in tobacco cessation will also be presented, along with findings from a survey and a systematic literature review.

Moderator:
- Paul Sinclair, President, FIP, Australia
- Lars-Åke Söderlund, Vice President, FIP, Sweden
- Long Chiau Ming, Professor and Associate Dean for Research and Postgraduate Studies, School of Medical and Life Sciences, Sunway University, Malaysia

Panellists:
- Vinayak M Prasad, Unit Head, WHO No Tobacco Unit(TFI), World Health Organization, Switzerland
- Inês Nunes da Cunha, Practice Development and Transformation Projects Manager, FIP, The Netherlands
- Sherly Meilianti, Data and Intelligence Specialist, FIP, United Kingdom
- Farah Aqqad, Data Integration Specialist , FIP, Jordan
- Raj Vaidya, Ex-Chairperson & Vice President, Community Pharmacy Division, Indian Pharmaceutical Association, India
- Husam ALSalamat, Chairperson of Continuous Professional Development CPD committee, Jordan Pharmacists Association, Jordan
- António Teixeira Rodrigues, Director, Evidence & Health Solutions, National Association of Pharmacies, Portugal

The Pharmaceutical Society of Kenya (PSK) is the umbrella body of Pharmacists in Kenya.

Over the years, PSK has been hosting annual scientific conferences for its members. In 2024, this conference will be a unique one as it will be held in collaboration with the International Society for Pharmacoepidemiology (ISPE) and will also mark the 60th anniversary of PSK. The annual conference is a platform that aligns with PSK’s mission to empower its members and uphold professionalism and ethics. The pharmaceutical sector is dynamic, influenced by technological advancements, policy changes, and the imperative of patient safety. Therefore, the 2024 conference is designed to assemble pharmacists and pharmacoepidemiologists from all over the world to delve into the theme ‘Pharmacists Transforming Policy, Practice, and Patient Safety’.

Abstract submission for the International Scientific Conference 2024 is ongoing.

Submit your abstract now: https://shorturl.at/jCNQY

Deadline: 2nd April 2024

The FIP Pharmacy Practice Research Special Interest Group (PPR SIG) is hosting another international event — “Pharmacy practice research summer meeting for PhD students, postdoctoral fellows and supervisors” — on 4 and 5 July 2024. This time the event will be online and the attendance will be free of charge.

The main scope of the PPR SIG is to increase pharmacy practice contributions to global health by providing greater access to the latest high-quality international pharmacy practice research. During this meeting both starting-out and experienced researchers will be given an opportunity to present their PPR research to an international audience. 

PhD students, postdoctoral researchers, academics, and practitioners involved in research are welcome to join this virtual meeting to present their research and disseminate their findings in a specialised forum .

The FIP Pharmacy Practice Research Special Interest Group (PPR SIG) is hosting another international event — “Pharmacy practice research summer meeting for PhD students, postdoctoral fellows and supervisors” — on 4 and 5 July 2024. This time the event will be online and the attendance will be free of charge.

The main scope of the PPR SIG is to increase pharmacy practice contributions to global health by providing greater access to the latest high-quality international pharmacy practice research. During this meeting both starting-out and experienced researchers will be given an opportunity to present their PPR research to an international audience. 

PhD students, postdoctoral researchers, academics, and practitioners involved in research are welcome to join this virtual meeting to present their research and disseminate their findings in a specialised forum .

The IMU School of Pharmacy is delighted to host the IMU International Pharmacy and Pharmaceutical Science Conference 2024 at the IMU campus, Kuala Lumpur, Malaysia,  in conjunction with the 20th Anniversary celebrations of the IMU Bachelor of Pharmacy (Hons) programme. This conference offers a pivotal platform for showcasing innovative research and practices in pharmacy & pharmaceutical science. It fosters collaborations and emphasises translating research in pharmacy and pharmaceutical sciences into global health solutions. Participants will partake in interdisciplinary discussion, exchange expertise, and forge partnerships with both local and international experts to advance the field.